CartiHeal Performs the First 17 Cases in the Agili-C™ Implant IDE Multinational Pivotal Study

October 2, 2017

KFAR SABA, Israel, Oct. 2, 2017 /PRNewswire/ -- CartiHeal, developer of Agili-C, proprietary implants for the treatment of joint surface lesions, announced today the initiation of Its IDE clinical study. 17 patients were enrolled and operated on during the first week of the study in 3 leading European centers. Read more here





Please reload

Please reload

Recent Posts

CartiHeal Performs First Agili-C™ Cartilage Repair Implantation Procedure in Maryland

October 15, 2019

Please reload

Featured Posts
Follow Us
Please reload

Search By Tags